HOME › DRUGS › BELANTAMAB MAFODOTIN
ACTIVE SUBSTANCE / INN

BELANTAMAB MAFODOTIN

Brand name(s): Blenrep
EMA LISTED
EXPIRED
AUTHORISED
Multiple Myeloma
ACTIVE SUBSTANCE
Belantamab Mafodotin
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BlenrepGlaxoSmithKline Trading Services LimitedAuthorised23/07/2025Multiple Myeloma
BlenrepGlaxoSmithKline Trading Services LimitedExpired25/08/2020Multiple Myeloma

FULL INTELLIGENCE ON BELANTAMAB MAFODOTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →